Stockhub

Klaria Pharma Holding AB: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 August 2022

  • curprev 05:3905:39, 16 August 2022 >Paris 680 bytes +680 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannab..."
Retrieved from "https://stockhub.co/research/Klaria_Pharma_Holding_AB"